Promise Ledger
Every outstanding corporate promise with a resolution deadline — and the ones that just resolved. Descriptive, sourced, receipt-backed.
No quarterly guidance · 7
A company that gave quarterly guidance at least six quarters in a row, then gave none for a quarter. Each entry is checked against the company's earnings release.- BAXFull-year guidance only: no quarterly guidance for Q1 of fiscal 2026, after at least 20 quarters with itFilingJun 30, 2026
- FTVFull-year guidance only: no quarterly guidance for Q3 of fiscal 2025, after at least 18 quarters with itFilingDec 30, 2025
- TGTFull-year guidance only: no quarterly guidance for Q1 of fiscal 2025, after at least 8 quarters with itFilingJun 30, 2025
- AVGOFull-year guidance only: no quarterly guidance for Q1 of fiscal 2024, after at least 14 quarters with itFilingJun 30, 2024
- DFull-year guidance only: no quarterly guidance for Q1 of fiscal 2024, after at least 14 quarters with itFilingJun 30, 2024
- IQVFull-year guidance only: no quarterly guidance for Q1 of fiscal 2023, after at least 12 quarters with itFilingJun 30, 2023
- RVTYFull-year guidance only: no quarterly guidance for Q1 of fiscal 2023, after at least 12 quarters with itFilingJun 30, 2023
Dividend activity · 300
Declared dividends, shown as history — descriptive, not scored, no verdict.Streaks & reversals
A company's recent run of kept promises, and runs that just reversed — descriptive, backward-looking.On a streak · 27
274 open · Buyback
- ITBuybackBoard of Directors increased the share repurchase authorization by $500 million in July 2026resolves in ~645 days
- DVNBuybackThe company also returned capital to shareholders through its new $8.0 billion share repurchase programresolves in ~645 days
- BRBuybackthe Board authorized a new share repurchase program under which Broadridge may repurchase up to $1.5 billion of its outstanding common stockresolves in ~645 days
- DOCBuybackHealthpeak's Board of Directors authorized a new $500 million share repurchase programresolves in ~645 days
- APTVBuyback$1.8 billion remained available for future share repurchasesresolves in ~645 days
- ZBHBuybackup to $1 billionresolves in ~646 days
- SNDKBuybackSandisk’s Board of Directors approving an additional $14 billion buyback programresolves in ~646 days
- BSQKZBuybackour board of directors authorized an increase to our share repurchase program of up to an additional $5 billionresolves in ~646 days
- CFBuybackSince CF Industries commenced its current $2 billion share repurchase program in October 2025resolves in ~646 days
- RMDBuybackGuiding to more than $1.85 billion in capital to be returned to shareholders through share repurchases and dividends during FY 2027resolves in ~647 days
- ABNBBuybackwe had the authorization to purchase up to $3.4 billion of our Class A common stockresolves in ~647 days
- CAHBuybackCardinal Health Board of Directors approved a $5.0 billion increase to the share repurchase programresolves in ~652 days
- TRMBBuybackThe Board of Directors authorized the repurchase of up to $1.0 billion in shares of the Company's common stockresolves in ~653 days
- ULTABuybackcurrent $3.0 billion share repurchase programresolves in ~668 days
- REGBuyback$200,000next filing due
- FFIVBuybackBoard of Directors has authorized an additional $1 billion for its common stock repurchase programnext filing due
- UHSBuybackour Board of Directors authorized a $1.0 billion increase to our stock repurchase programnext filing due
- LVSBuybackThe LVS Board of Directors has authorized $2.0 billion of share repurchases in the futurenext filing due
- LMTBuybackincreasing the total authorization for potential future common stock repurchases to $10.3 billionnext filing due
- NUEBuybackNucor had approximately $1.42 billion remaining authorized and available for repurchases under its share repurchase program.next filing due
- SLBBuybackWe now expect to exceed the $3.0 billion return to shareholders commitment we made earlier this year.next filing due
- UALBuybackThe company's Board of Directors authorized a new share repurchase program for up to $1.5 billion of outstanding sharesnext filing due
- JBLBuybackThe Board of Directors has authorized a share repurchase program of up to $1 billion in common stock.next filing due
- FDXBuybackFedEx expects to repurchase an additional $1.5 billion of common stock during fiscal 2025, for a buyback total of $2.5 billionnext filing due
- PANWBuybackThe board of directors authorized an additional $500 million for share repurchasesnext filing due